Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Knee Injury or Cartilage Injury
and you are
between 18 and 50
years old
The phase for this study is not defined.
Show me locations

The purpose

114 patients between 18 and 50 years with an isolated focal cartilage defect in the knee will be randomized to either receive arthroscopic microfracture or arthroscopic debridement. Both groups will then undergo a systematic physiotherapy training regime for 6-9 months. The groups will then be compared for results, after 3, 6, 12 and 24 months, by using validated patient reported outcome scores (Lysholm, KOOS, Tegner) and EQ5D as well as clinical examination and radiological findings at 2 years (MRI).

Provided treatments

  • Procedure: Arthroscopic microfracture (MF)
  • Procedure: Arthroscopic debridement (AD)
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02637505. The sponsor of the trial is University Hospital, Akershus and it is looking for 114 volunteers for the current phase.
Official trial title:
Focal Cartilage Defects in the Knee - A Randomized Controlled Trial Comparing Arthroscopic Microfracture With Arthroscopic Debridement